
MARIA JOSE
ALCARAZ TORMO
CATEDRÀTIC/A D'UNIVERSITAT
Publications (202) MARIA JOSE ALCARAZ TORMO publications
2024
-
Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis
Biochemical Pharmacology, Vol. 228
-
Hyaluronic Acid Hampers the Inflammatory Response Elicited by Extracellular Vesicles from Activated Monocytes in Human Chondrocytes
Pharmaceutics, Vol. 16, Núm. 11
-
Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression
International Journal of Molecular Sciences, Vol. 25, Núm. 5
2022
-
Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis
Stem cells translational medicine, Vol. 11, Núm. 12, pp. 1177-1185
-
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
International journal of molecular sciences, Vol. 23, Núm. 15
2021
-
Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with Osteoarthritis
Methods in Molecular Biology (Humana Press Inc.), pp. 221-231
-
Extracellular vesicles do not mediate the anti-inflammatory actions of mouse-derived adipose tissue mesenchymal stem cells secretome
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-14
-
New potential therapeutic approaches targeting synovial fibroblasts in rheumatoid arthritis
Biochemical Pharmacology, Vol. 194
-
Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells
Journal of Orthopaedic Translation, Vol. 30, pp. 61-69
2020
-
Extracellular vesicles from mesenchymal stem cells as novel treatments for musculoskeletal diseases
Cells, Vol. 9, Núm. 1
-
Pharmacological modulation of redox signaling pathways in disease
Free Radical Biology and Medicine
-
Relevance of Nrf2 and heme oxygenase-1 in articular diseases
Free Radical Biology and Medicine, Vol. 157, pp. 83-93
2019
-
Emerging therapeutic agents in osteoarthritis
Biochemical Pharmacology, Vol. 165, pp. 4-16
-
Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases
Cells, Vol. 9, Núm. 1
-
Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis
International Journal of Molecular Sciences, Vol. 20, Núm. 16
2018
-
Extracellular vesicles: A new therapeutic strategy for joint conditions
Biochemical Pharmacology, Vol. 153, pp. 134-146
-
Fármacos antireumáticos y antigotosos
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 519-530
-
Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes
Cellular Physiology and Biochemistry, Vol. 47, Núm. 1, pp. 11-25
-
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Journal of Extracellular Vesicles, Vol. 7, Núm. 1
-
Myeloid heme oxygenase-1 regulates the acute inflammatory response to zymosan in the mouse air pouch
Oxidative Medicine and Cellular Longevity, Vol. 2018